Charles River rejigs exec roles and preclinical organisation
US CRO Charles River (CRL) has unveiled a raft of executive changes and plans to restructure its PCS unit to provide customers with a more centralised approach to global drug development.
US CRO Charles River (CRL) has unveiled a raft of executive changes and plans to restructure its PCS unit to provide customers with a more centralised approach to global drug development.
The Spanish Ministry of Health is leading a €60m ($84.9m) programme that will build the country’s first vaccine production facility and use Novavax’s recombinant virus-like-particle (VLP) technology.
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including the new president of Sanofi-Aventis France.
Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.
UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.
Dow Chemical is closing three US manufacturing plants, including an ethylene production unit in Hahnville, Louisiana in a further bid to restructure its specialty chemicals business.